​
​

Omnicell (OMCL) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

OMCL Stock Forecast

Omnicell stock forecast is as follows: an average price target of $83.50 (represents a 89.30% upside from OMCL’s last price of $44.11) and a rating consensus of 'Hold', based on 7 wall street analysts offering a 1-year stock forecast.

OMCL Price Target

The average price target for Omnicell (OMCL) is $83.50 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $158.00 to $57.00. This represents a potential 89.30% upside from OMCL's last price of $44.11.

OMCL Analyst Ratings

Hold

According to 7 Wall Street analysts, Omnicell's rating consensus is 'Hold'. The analyst rating breakdown for OMCL stock is 0 'Strong Buy' (0.00%), 3 'Buy' (42.86%), 4 'Hold' (57.14%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Omnicell Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 31, 2024Stephanie DavisBarclays--9.33%31.49%
Aug 05, 2024Sean WielandPiper Sandler--52.50%38.29%
Aug 02, 2024Stephanie DavisBarclays---0.56%-11.58%
Nov 18, 2022J.P. Morgan--6.28%29.22%
Aug 08, 2022Jessica TassanPiper Sandler--37.46%240.06%
Jun 16, 2022Stan BerenshteynWells Fargo--43.87%258.20%
May 03, 2022Piper Sandler--40.99%267.26%
Row per page
Go to

The latest Omnicell stock forecast, released on Oct 31, 2024 by Stephanie Davis from Barclays, set a price target of $58.00, which represents a 9.33% increase from the stock price at the time of the forecast ($53.05), and a 31.49% increase from OMCL last price ($44.11).

Omnicell Price Target by Period

1M3M12M
# Anlaysts113
Avg Price Target$58.00$58.00$52.67
Last Closing Price$44.11$44.11$44.11
Upside/Downside31.49%31.49%19.41%

In the current month, the average price target of Omnicell stock is $58.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 31.49% increase as opposed to Omnicell's last price of $44.11. This month's average price target is down 0.00% compared to last quarter, and up 10.12% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 11, 2024Bank of America SecuritiesNeutralNeutralHold
Oct 31, 2024Craig-HallumBuyBuyHold
Oct 31, 2024BarclaysEqual-WeightEqual-WeightHold
Oct 14, 2024Wells FargoEqual-WeightEqual-WeightHold
Oct 09, 2024BenchmarkUnderperformUnderperformHold
Oct 09, 2024Wells FargoBuyBuyHold
Sep 11, 2024KeyBancSector WeightSector WeightHold
Aug 23, 2024Wells FargoBuyBuyHold
Aug 05, 2024Piper SandlerOverweightOverweightHold
Aug 02, 2024BarclaysEqual-WeightUpgrade
Row per page
Go to

Omnicell's last stock rating was published by Bank of America Securities on Nov 11, 2024. The company gave OMCL a "Neutral" rating, the same as its previous rate.

Omnicell Financial Forecast

Omnicell Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$258.85M$298.66M$298.97M$290.63M$297.67M$348.06M$331.39M$318.83M$311.03M$296.40M$272.74M$251.84M$249.20M$213.70M$199.62M$229.69M$248.29M$228.81M
Avg Forecast$301.49M$297.75M$292.43M$272.23M$307.15M$294.72M$287.66M$270.83M$297.85M$280.44M$254.41M$236.77M$255.52M$295.47M$284.52M$277.65M$287.16M$363.23M$339.45M$314.36M$311.08M$284.74M$268.57M$246.72M$245.69M$208.88M$182.42M$218.99M$243.69M$231.86M
High Forecast$307.05M$303.24M$297.82M$277.25M$312.81M$300.15M$292.97M$271.89M$303.34M$280.46M$254.41M$236.77M$258.01M$296.21M$289.77M$282.77M$292.45M$363.23M$339.45M$314.36M$311.08M$284.74M$268.57M$246.72M$245.69M$208.88M$182.42M$218.99M$243.69M$231.86M
Low Forecast$292.80M$289.17M$284.00M$264.39M$298.30M$286.23M$279.37M$269.75M$289.26M$280.42M$254.41M$236.77M$252.11M$293.74M$276.32M$269.65M$278.88M$363.23M$339.45M$314.36M$311.08M$284.74M$268.57M$246.72M$245.69M$208.88M$182.42M$218.99M$243.69M$231.86M
# Analysts222211144222476322223456633322
Surprise %------------1.01%1.01%1.05%1.05%1.04%0.96%0.98%1.01%1.00%1.04%1.02%1.02%1.01%1.02%1.09%1.05%1.02%0.99%

Omnicell's average Quarter revenue forecast for Mar 24 based on 2 analysts is $236.77M, with a low forecast of $236.77M, and a high forecast of $236.77M. OMCL's average Quarter revenue forecast represents a -8.53% decrease compared to the company's last Quarter revenue of $258.85M (Dec 23).

Omnicell EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211144222476322223456633322
EBITDA------------$72.19M$3.71M$31.80M$1.26M$-13.74M$43.20M$37.87M$29.52M$29.83M$44.48M$43.24M$33.39M$33.88M$28.62M$10.39M$28.05M$38.65M$39.82M
Avg Forecast$29.49M$29.13M$28.61M$26.63M$30.05M$28.83M$28.14M$26.49M$29.14M$27.43M$24.89M$32.48M$25.00M$28.91M$27.83M$29.53M$38.08M$41.71M$38.98M$23.34M$35.72M$32.70M$30.84M$24.79M$28.21M$23.99M$20.95M$21.17M$27.98M$26.63M
High Forecast$30.04M$29.67M$29.14M$27.12M$30.60M$29.36M$28.66M$26.60M$29.68M$27.44M$24.89M$38.98M$25.24M$28.98M$28.35M$35.44M$45.69M$41.71M$38.98M$28.01M$35.72M$32.70M$30.84M$29.75M$28.21M$23.99M$20.95M$25.41M$27.98M$26.63M
Low Forecast$28.64M$28.29M$27.78M$25.86M$29.18M$28.00M$27.33M$26.39M$28.30M$27.43M$24.89M$25.99M$24.66M$28.74M$27.03M$23.62M$30.46M$41.71M$38.98M$18.68M$35.72M$32.70M$30.84M$19.83M$28.21M$23.99M$20.95M$16.94M$27.98M$26.63M
Surprise %------------2.89%0.13%1.14%0.04%-0.36%1.04%0.97%1.26%0.84%1.36%1.40%1.35%1.20%1.19%0.50%1.33%1.38%1.50%

2 analysts predict OMCL's average Quarter EBITDA for Mar 24 to be $32.48M, with a high of $38.98M and a low of $25.99M. This is -55.00% lower than Omnicell's previous annual EBITDA (Dec 23) of $72.19M.

Omnicell Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211144222476322223456633322
Net Income------------$-14.38M$5.55M$3.45M$-15.00M$-28.41M$16.77M$9.07M$8.21M$13.98M$29.32M$20.42M$14.13M$16.38M$8.80M$-4.30M$11.31M$22.09M$19.98M
Avg Forecast$25.07M$26.46M$26.00M$25.07M$25.00M$23.81M$21.62M$14.46M$26.46M$19.46M$6.70M$9.11M$7.14M$21.62M$13.10M$8.28M$15.38M$43.94M$39.13M$6.55M$42.49M$42.01M$38.06M$10.49M$37.35M$22.43M$10.53M$8.54M$35.97M$32.75M
High Forecast$25.67M$27.10M$26.62M$25.67M$25.60M$24.38M$22.14M$15.24M$29.52M$19.63M$6.71M$10.93M$9.25M$22.54M$13.42M$9.94M$18.45M$43.94M$39.13M$7.86M$42.49M$42.01M$38.06M$12.59M$37.35M$22.43M$10.53M$10.24M$35.97M$32.75M
Low Forecast$24.13M$25.47M$25.03M$24.13M$24.07M$22.92M$20.81M$13.68M$21.37M$19.30M$6.69M$7.29M$5.04M$19.32M$12.61M$6.63M$12.30M$43.94M$39.13M$5.24M$42.49M$42.01M$38.06M$8.39M$37.35M$22.43M$10.53M$6.83M$35.97M$32.75M
Surprise %-------------2.01%0.26%0.26%-1.81%-1.85%0.38%0.23%1.25%0.33%0.70%0.54%1.35%0.44%0.39%-0.41%1.33%0.61%0.61%

Omnicell's average Quarter net income forecast for Dec 23 is $7.14M, with a range of $5.04M to $9.25M. OMCL's average Quarter net income forecast represents a 28.65% increase compared to the company's last Quarter net income of $5.55M (Sep 23).

Omnicell SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211144222476322223456633322
SG&A------------$101.95M$103.97M$103.56M$125.11M$131.70M$115.46M$119.25M$119.93M$115.76M$97.91M$89.17M$86.59M$87.96M$71.44M$69.39M$78.82M$82.33M$70.88M
Avg Forecast$106.49M$105.17M$103.29M$96.16M$108.49M$104.10M$101.61M$95.66M$105.21M$99.06M$89.86M$133.03M$90.25M$104.37M$100.50M$120.93M$127.33M$127.75M$119.39M$95.60M$109.41M$100.15M$94.46M$64.29M$86.41M$73.47M$64.16M$59.49M$85.71M$81.55M
High Forecast$108.46M$107.11M$105.20M$97.93M$110.49M$106.02M$103.48M$96.04M$107.15M$99.06M$89.86M$159.63M$91.14M$104.63M$102.35M$145.12M$152.80M$127.75M$119.39M$114.72M$109.41M$100.15M$94.46M$77.15M$86.41M$73.47M$64.16M$71.38M$85.71M$81.55M
Low Forecast$103.42M$102.14M$100.32M$93.39M$105.37M$101.10M$98.68M$95.28M$102.17M$99.05M$89.86M$106.42M$89.05M$103.76M$97.60M$96.75M$101.87M$127.75M$119.39M$76.48M$109.41M$100.15M$94.46M$51.43M$86.41M$73.47M$64.16M$47.59M$85.71M$81.55M
Surprise %------------1.13%1.00%1.03%1.03%1.03%0.90%1.00%1.25%1.06%0.98%0.94%1.35%1.02%0.97%1.08%1.33%0.96%0.87%

Omnicell's average Quarter SG&A projection for Mar 24 is $133.03M, based on 2 Wall Street analysts, with a range of $106.42M to $159.63M. The forecast indicates a 30.48% rise compared to OMCL last annual SG&A of $101.95M (Dec 23).

Omnicell EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts222211144222476322223456633322
EPS------------$-0.32$0.12$0.08$-0.33$-0.64$0.38$0.21$0.19$0.32$0.67$0.47$0.33$0.39$0.21$-0.10$0.27$0.53$0.48
Avg Forecast$0.54$0.57$0.56$0.54$0.54$0.51$0.47$0.31$0.57$0.42$0.14$-0.09$0.15$0.47$0.28$0.07$0.08$0.95$0.85$0.69$0.92$0.91$0.83$0.66$0.81$0.49$0.23$0.51$0.78$0.71
High Forecast$0.55$0.58$0.57$0.55$0.55$0.53$0.48$0.33$0.64$0.42$0.14$-0.09$0.20$0.49$0.29$0.07$0.08$0.95$0.85$0.69$0.92$0.91$0.83$0.66$0.81$0.49$0.23$0.51$0.78$0.71
Low Forecast$0.52$0.55$0.54$0.52$0.52$0.49$0.45$0.29$0.46$0.42$0.14$-0.10$0.11$0.42$0.27$0.07$0.08$0.95$0.85$0.69$0.92$0.91$0.83$0.66$0.81$0.49$0.23$0.51$0.78$0.71
Surprise %-------------2.08%0.26%0.28%-4.88%-7.78%0.40%0.25%0.28%0.35%0.73%0.57%0.50%0.48%0.43%-0.44%0.53%0.68%0.67%

According to 4 Wall Street analysts, Omnicell's projected average Quarter EPS for Dec 23 is $0.15, with a low estimate of $0.11 and a high estimate of $0.20. This represents a 28.23% increase compared to OMCL previous annual EPS of $0.12 (Sep 23).

Omnicell Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CMAXCareMax--288.06%Hold
EVHEvolent Health--252.55%Buy
DHDefinitive Healthcare--123.53%Hold
FORAForian--115.31%Buy
CERTCertara--97.85%Buy
OMCLOmnicell--89.30%Hold
HSTMHealthStream---8.86%Buy

OMCL Forecast FAQ

Is Omnicell a good buy?

No, according to 7 Wall Street analysts, Omnicell (OMCL) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 42.86% of OMCL's total ratings.

What is OMCL's price target?

Omnicell (OMCL) average price target is $83.5 with a range of $57 to $158, implying a 89.30% from its last price of $44.11. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Omnicell stock go up soon?

According to Wall Street analysts' prediction for OMCL stock, the company can go up by 89.30% (from the last price of $44.11 to the average price target of $83.5), up by 258.20% based on the highest stock price target, and up by 29.22% based on the lowest stock price target.

Can Omnicell stock reach $70?

OMCL's average twelve months analyst stock price target of $83.5 supports the claim that Omnicell can reach $70 in the near future.

What is Omnicell's current price target trend?

1 Wall Street analyst forecast a $58 price target for Omnicell (OMCL) this month, up 31.49% from its last price of $44.11. Compared to the last 3 and 12 months, the average price target increased by 31.49% and increased by 19.41%, respectively.

What are Omnicell's analysts' financial forecasts?

Omnicell's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.16B (high $1.18B, low $1.13B), average EBITDA is $113.52M (high $115.22M, low $110.9M), average net income is $84.9M (high $87.36M, low $81.47M), average SG&A $409.87M (high $416.04M, low $400.43M), and average EPS is $1.83 (high $1.88, low $1.75). OMCL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.16B (high $1.19B, low $1.13B), average EBITDA is $113.86M (high $115.96M, low $110.58M), average net income is $102.6M (high $105.06M, low $98.76M), average SG&A $411.12M (high $418.7M, low $399.27M), and average EPS is $2.21 (high $2.26, low $2.13).

Did the OMCL's actual financial results beat the analysts' financial forecasts?

Based on Omnicell's last annual report (Dec 2023), the company's revenue was $1.15B, beating the average analysts forecast of $1.11B by 3.05%. Apple's EBITDA was $60.69M, missing the average prediction of $111.27M by -45.46%. The company's net income was $-20.371M, missing the average estimation of $50.15M by -140.62%. Apple's SG&A was $434.59M, beating the average forecast of $416.05M by 4.46%. Lastly, the company's EPS was $-0.45, missing the average prediction of $0.969 by -146.42%. In terms of the last quarterly report (Dec 2023), Omnicell's revenue was $258.85M, beating the average analysts' forecast of $255.52M by 1.30%. The company's EBITDA was $72.19M, beating the average prediction of $25M by 188.81%. Omnicell's net income was $-14.375M, missing the average estimation of $7.14M by -301.21%. The company's SG&A was $101.95M, beating the average forecast of $90.25M by 12.96%. Lastly, the company's EPS was $-0.32, missing the average prediction of $0.154 by -307.95%